Search
for
Sort by
Research 391–420 of 1000+
- Translating Resveratrol Research: A Systematic Review on Patents and Clinical Trials (2000–2025)
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy
- PCA: A tFNA-based targeted nucleic acid nanocomposite hydrogel for the treatment of androgenetic alopecia through the promotion of angiogenesis and hair follicle stem cell proliferation
- Stem cell-based therapies for alopecia areata: a narrative review
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Promises and Pitfalls of Regenerative Therapies for Androgenetic Alopecia: Platelet-Rich Plasma, Photobiomodulation, Stem Cells, and Exosomes
- Severe Acute SARS-CoV-2 Infection and Long COVID: What Do We Know So Far? New Challenges in Diagnosis and Management
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Poster Presentations at the 28th Joint Meeting of the International Society of Dermatopathology, March 5–6, 2025, Orlando, Florida, USA
- Update From Dermatology Nurses’ Association Convention 2025
- Prevalence and Patterns of Dermatological Diseases in Lesbian, Gay, Bisexual, Transgender, and Queer Population: A Cross-Sectional Survey
- Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities
- Ernährungsstörungen des Haares und deren Management
- Cutaneous epitheliotropic T‐cell lymphoma in a sugar glider (<i>Petaurus breviceps</i>)
- Epidermal growth factor receptor inhibitor Geftinib-induced erosive pustular dermatosis of the scalp – A report with a brief review of the literature
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)
- An Updated in the Management of Alopecia Areata
- Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases
- The potential of regulatory T cell-based therapies for alopecia areata
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- TONGUE, RED
- A Cross-Sectional Study on the Prevalence of Premature Canities Among University Students in the Eastern Province, Kingdom of Saudi Arabia
- Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
- Advanced Intelligent Systems for Surgical Robotics
- Hidradenitis Suppurativa as a Potential Subtype of Autoinflammatory Keratinization Disease
- Intense Pulsed Light: From the Past to the Future
- Platelet-rich plasma—an ‘Elixir’ for treatment of alopecia: personal experience on 117 patients with review of literature
- Rapp-Hodgkin syndrome: A review of the aspects of hair and hair color
- Emergence of the natural history of Myhre syndrome: 47 patients evaluated in the Massachusetts General Hospital Myhre Syndrome Clinic (2016–2023)